• DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
      • Media workshops
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
  • DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
      • Media workshops
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
Home > Press releases

Launch of first platform for emergency research preparedness and response in Africa

PANTHER will pounce on pandemics in remote, at-risk areas before they break

Home > Press releases

Launch of first platform for emergency research preparedness and response in Africa

PANTHER will pounce on pandemics in remote, at-risk areas before they break

Researcher looking into a microscope
14 Dec 2022

PANTHER brings together leading African and global researchers and public health teams, who will work together through regional hubs to help countries and communities to better prepare, pounce, and bounce back, before emerging infectious diseases become pandemics.  Ready-made, disease specific research kits and no regrets-investment will be key for these risky hot-spots.

‘To not prepare for outbreaks is to prepare for failure – if we want to adapt research, diagnostics and medicines to our needs, Africa needs take the lead now,’ said Dr Samba Sow, Director General at the Centre for Vaccine Development, Mali and Chair of the Pandemic Preparedness Platform for Health and Emerging Infection Response (PANTHER).

Though Africa makes up 15% of the world’s population and 25% of global disease burden, in 2016 it accounted for just 1.1% of global research and development spending; of this, two-thirds was focused in just three countries: Egypt, Nigeria, and South Africa.

‘COVID was a stark reminder of why Africa needs to be self-reliant and to invest in research capacity, better infrastructure and surveillance, so we can react fast, with adapted solutions in rural or remote primary health care areas,’ said Dr Mahlet Kifle Habtemariam, Senior Regional Engagement Advisor, Africa CDC and PANTHER board member.

To help bridge the gap, PANTHER will focus on emerging disease hotspots and at-risk communities, while working closely with Africa CDC and the New Public Health Order, with WHO, ministries of health, and at-risk communities. PANTHER will create a network of equipped and trained researchers, combining experienced African research centres with healthcare sites, in both major cities and more remote areas.

PANTHER hubs will target key Africa CDC and WHO hot spot diseases like Lassa Fever and Killer Flu, with a two-pronged, parallel Map and Engage Approach: mapping the innovators and developers per target disease; and engaging and aligning key stakeholders, including health workers and communities, before diseases break out; to be better prepared to then develop, deploy, and deliver in emergencies, together.

In COVID months of precious time was wasted reinventing basic R&D tools like clinical trial protocols or legal and research contracts. Too often, potential drug candidates stay on a shelf until needed, as research and development processes, including clinical trials, can take years. Too late for outbreaks and pandemics.

‘PANTHER will go where early cases of target diseases are, with 80% ready-made Emergency Research Kits, which can be rapidly adapted to the specific local and immunity/ disease needs. So instead of traveling 300-600 km with samples, we can test on the spot, share and assess the results, then move safely and rapidly onto clinical trials, save lives,’ said Dr Nathalie Strub-Wourgaft, General Delegate of PANTHER.

Africa needs sustained, ‘no-regrets’ investment to strengthen research and pandemic response to pounce on the source of the disease, in at-risk areas, especially in remote or rural regions, even if the outbreaks may never happen. A key challenge for Africa is that most funding still comes from abroad. A Kenyan study found of the top 15 funders for COVID research, only three are African – all from South Africa.[1] Yet Africa makes up 15% of the world’s population and 25% of global disease burden, in 2016 it made up just 1.1% of global R&D spending, of this, 65.7%, was focused in just three countries: Egypt, Nigeria, and South Africa.

[1] Investing in health R&D: where we are, what limits us, and how to make progress in Africa

Media contact

media@dndi.org

Photo credit: Lameck Ododo-DNDi

Pandemic Preparedness Africa

Read, watch, share

Loading...
News
6 Jun 2025

DNDi is partnering with Médecins Sans Frontières South Asia for the Without Borders Media Fellowship 2025 

News
5 Jun 2025

Meet the DNDi Eastern Africa 2024-2025 Media Fellows

Press releases
5 Jun 2025

Colombia becomes first country to recommend rapid tests to diagnose Chagas disease

Statements
27 May 2025

DNDi interventions at the 78th World Health Assembly

Press releases
22 May 2025

Six African nations commit to eliminate deadly neglected disease visceral leishmaniasis

Videos
20 May 2025

The Children of the Sierra

Press releases
13 May 2025

First all-oral treatment for a rare but deadly strain of sleeping sickness now available and being used to treat patients in endemic countries in Africa

Statements
8 May 2025

DNDi’s briefing note for 78th World Health Assembly

VIEW ALL

Help neglected patients

To date, we have delivered thirteen new treatments, saving millions of lives.

Our goal is to deliver 25 new treatments in our first 25 years. You can help us get there. 

GIVE NOW
Linkedin-in Instagram Twitter Facebook-f Youtube
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

  • Diseases
  • Neglected tropical diseases
  • R&D portfolio
  • Policy advocacy

Get in touch

  • Our offices
  • Contact us
  • Integrity Line

Support us

  • Donate
  • Subscribe to eNews

Work with us

  • Join research networks
  • Jobs
  • RFPs
  • Terms of Use   
  •   Acceptable Use Policy   
  •   Privacy Policy   
  •   Cookie Policy   
  •   Our policies   

  • Except for images, films and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Switzerland License